Shing Yue Sheung
NAVi Medical Technologies
NAVi Medical Technologies, based in Melbourne, Australia, is developing a way to provide accurate localisation of umbilical venous catheters in critically-ill newborns to achieve better patient outcomes.
The neoNAV, NAVi’s first product, leverages ECG data and machine learning to accurately locate the tip of a UVC in real-time during the insertion procedure. The neoNAV is an essential solution in reducing the risk of patient complications, improving the current clinical procedure, and better hospital efficiency.
“The team at NAVi shares a vision of improving a delicate procedure performed in the most vulnerable of patients.” said Shing Yue Sheung, COO. “Being part of TMCx is providing us with a fantastic opportunity to accelerate the commercialization of our product and to engage with key stakeholders in the U.S. so we can raise the standard of neonatal care beyond Australia.”